Medicine & TechnologyThe World Health Organization recommended yesterday RTS,S, or Mosquirix, the only brand approved for its malaria vaccine efficacy rate.
Scientists at the University of North Carolina at Chapel Hill and GlaxoSmithKline are homing in on a breakthrough in the fight against AIDS-one that has remained out of reach: finding a cure. This partnership between the private company and the public university will marry the longstanding work of each entity to hopefully arrive at more than has seemed possible in even the recent past.
The leading malaria vaccine candidate has shown disappointing results, the final study showing that in many cases it simply doesn't work very well and that the initial protection fades with time.